Skip to Content
Merck
  • Solvent proton magnetic resonance dispersion in protocatechuate 3,4-dioxygenase and complexes with 3-halo-4-hydroxybenzoate inhibitors.

Solvent proton magnetic resonance dispersion in protocatechuate 3,4-dioxygenase and complexes with 3-halo-4-hydroxybenzoate inhibitors.

Biochemistry (1984-08-14)
R H Felton, S L Gordon, A L Sowell, S W May
ABSTRACT

Solvent proton nuclear magnetic dispersion studies at 25, 100, and 300 MHz have been performed on protocatechuate 3,4-dioxygenase (PCD) and its complexes with 3-chloro-4-hydroxybenzoate and 3-fluoro-4-hydroxybenzoate. Longitudinal and transverse relaxation rates were measured for these compounds and for the apoenzyme. The paramagnetic enhancement of solvent T1 is interpreted in terms of dominant dipole-dipole relaxation of fast-exchanging solvent protons with a negligible contribution from outer sphere relaxation and an electronic spin relaxation time of 0.5 ns for the high-spin ferric ion. A discrepancy between the observed T2 at 300 MHz and that calculated by assuming the usual dipolar relaxation provides evidence for an additional Curie-spin dipolar or hyperfine interaction between the proton and iron. Quantitation of the additional relaxivity provides an estimated chemical exchange lifetime of 0.1-0.14 microseconds, which suggests proton exchange by a hydroxide ligand. Proton-to-iron distances are 2.7-3.1 A in PCD and lengthen to 3.6-4.1 A in the halohydroxybenzoate complexes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
3-Chloro-4-hydroxybenzoic acid hemihydrate, 98%
Sigma-Aldrich
3-Fluoro-4-hydroxybenzoic acid, 95%